Life-threatening desquamating rash and hyperammonemia following administration of eculizumab for paroxysmal nocturnal hemoglobinuria

Am J Hematol. 2008 Nov;83(11):881-3. doi: 10.1002/ajh.21265.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal, Humanized
  • Complement C5 / antagonists & inhibitors*
  • Dermatitis, Exfoliative / chemically induced*
  • Hemoglobinuria, Paroxysmal / drug therapy*
  • Humans
  • Immunologic Factors / adverse effects
  • Male

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Complement C5
  • Immunologic Factors
  • eculizumab